載入...

Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells

Antibodies targeting the PD-1/PD-L1 immune checkpoint achieved spectacular success in anticancer therapy in the recent years. In contrast, no small molecules with cellular activity have been reported so far. Here we provide evidence that small molecules are capable of alleviating the PD-1/PD-L1 immu...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Skalniak, Lukasz, Zak, Krzysztof M., Guzik, Katarzyna, Magiera, Katarzyna, Musielak, Bogdan, Pachota, Magdalena, Szelazek, Bozena, Kocik, Justyna, Grudnik, Przemyslaw, Tomala, Marcin, Krzanik, Sylwia, Pyrc, Krzysztof, Dömling, Alexander, Dubin, Grzegorz, Holak, Tad A.
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2017
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5641120/
https://ncbi.nlm.nih.gov/pubmed/29069777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20050
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!